Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency

Bone Marrow Transplantation

Volumn 19, Issue 12, 1997, Pages 1229-1232

  Pasic, S ^a   Flannagan, L ^a   Cant, A J ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bone marrow transplant; Children; Liposomal amphotericin B; Primary immunodeficiency

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CREATININE; CYCLOSPORIN; FOSCARNET; POTASSIUM; VANCOMYCIN;

ARTICLE; BIOCHEMISTRY; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG TOLERABILITY; DRUG TOXICITY; FEMALE; FEVER; FUNGUS CULTURE; HUMAN; HYPOKALEMIA; IMMUNE DEFICIENCY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; MYCOSIS; NEPHROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0030761819     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700821     Document Type: Article

References (9)

1. Baley JE, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr 1990; 11: 791-797.
2. Tollemar J, Ringden O, Tyden G. Liposomal amphotericin (AmBisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation. Clin Transplant 1990; 4: 167-175.
3. Vincent M, Webster MH, Pether JVS. Liposomal amphotericin B. Lancet 1992; i: 375 (letter).
4. Chopra R, Blair S, Strang J et al. Liposomal amphotericin in the treatment of fungal infections in neutropenic patients. J Antimicrob Chemother 1991; 28 (Suppl. B): 93-104.
5. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infection in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol 1994; 86: 754-760.
6. Gallis HA, Drew RH, Pickard WW. Amphotericin B - 30 years of clinical experience. Rev Infect Dis 1990; 12: 308-329.
7. Van't Vout JW, Mattie H, Van Furth R. Comparison of efficies of amphotericin B, fluconazole and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother 1989; 33: 147-151.
8. Ringden O, Andstrom E, Remberger M et al. Safety of liposomal amphotericin (AmBisome) in 187 bone marrow transplant recipients treated with cyclosporin. Bone Marrow Transplant 1994; 14 (Suppl. 5): 10-14.
9. Ringden O, Tollemar J, Dahllof G, Tyden G. High cure rate of invasive fungal infections in immunocompromised children using AmBisome. Transplantation Proc 1994; 26: 175-177.